-
Sisomicin vs. Tobramycin in Clinical Isolates
2026-08-17
Stewart and Bodey evaluated sisomicin against 565 clinical isolates and found activity broadly comparable to gentamicin and Tobramycin, with stronger activity than kanamycin and butirosin against most Gram-negative bacilli. The study also showed that gentamicin- and Tobramycin-resistant isolates were generally resistant to sisomicin, while many remained susceptible to amikacin.
-
Dihydrotestosterone (DHT) Workflows for AR Research
2026-08-17
Use Dihydrotestosterone (DHT) as a controlled androgen receptor stimulus to connect receptor activation with EGFR, ERBB2, AKT, and ERK pathway outputs. This practical guide also shows how DHT can complement tumor–microenvironment studies of anti-androgen resistance without confusing direct AR effects with stromal mechanisms.
-
Annexin V-PE Apoptosis Detection Kit: PS to Pathway
2026-08-16
The Annexin V-PE Apoptosis Detection Kit connects phosphatidylserine externalization with mechanistic studies of drug-induced cell death. This guide explains how to interpret live-cell Annexin V-PE data alongside pathway analysis, using recent ALK-positive lymphoma research as a practical model.
-
Q-VD-OPh for Reliable Apoptosis Assays
2026-08-15
Learn how Q-VD-OPh (SKU A1901) can help researchers distinguish caspase-dependent apoptosis from upstream mitochondrial events, improve post-cryopreservation viability assessments, and design more interpretable cytotoxicity assays. The article combines product specifications with recent BAX–BAK mechanistic evidence and practical workflow guidance.
-
V5 Epitope Tag Peptide: Applied Workflow Guide
2026-08-14
Use the V5 Epitope Tag Peptide as a compact recognition handle for recombinant protein expression, Western blotting, immunoprecipitation, and localization studies. Its strongest practical advantage is assay flexibility: the same sequence can support routine detection, peptide-competition controls, antibody benchmarking, and advanced exchangeable-probe imaging.
-
DMH1, ALK2 Inhibition, and Organoid Control
2026-08-14
A translational perspective on using DMH-1 to interrogate BMP-dependent fate decisions, connect organoid engineering with non-small cell lung cancer research, and improve mechanistic reproducibility.
-
Pregnenolone Carbonitrile: PXR Workflow Guide
2026-08-13
Pregnenolone Carbonitrile enables controlled rodent PXR activation for cytochrome P450 induction, hepatic detoxification, and antifibrotic experiments. This practical guide connects formulation, assay design, and troubleshooting with a newly reported adenine-induced HFsnEF model without overstating PCN-specific evidence.
-
Mitoxantrone Workflows for ABCG2 Resistance
2026-08-13
Mitoxantrone combines topoisomerase II inhibition with a practical readout for studying ABCG2-mediated drug efflux. This guide translates recent marein findings into cell-based accumulation, viability, apoptosis, and resistance-reversal workflows while addressing solubility, fluorescence, and assay-design pitfalls.
-
Imidazoline Blockade of β-Cell K+ Channels
2026-08-12
The reference study showed that several imidazoline α2-adrenoceptor antagonists enhance insulin release primarily by blocking ATP-sensitive K+ channels in pancreatic β-cells, rather than through adrenoceptor antagonism alone. Its combined use of 86Rb efflux, whole-cell patch clamp, and functional insulin-release assays provides a rigorous framework for distinguishing receptor-mediated effects from direct ion-channel pharmacology.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-08-12
Learn how to use JC-1 red-to-green fluorescence to connect mitochondrial depolarization with apoptosis, drug response, and mitochondrial function analysis. This workflow emphasizes matched controls, ratio-based interpretation, and practical troubleshooting for cells, tissue mitochondria, and purified mitochondrial preparations.
-
UK-5099 for Mitochondrial Metabolism Research
2026-08-11
UK-5099 (PF-1005023) provides a practical way to test how mitochondrial pyruvate entry shapes immune-cell activation, cellular energy balance, and glucose handling. This guide translates standardized whole-blood stimulation into reproducible assay workflows, controls, and troubleshooting decisions.
-
Etoposide Nanoparticles for Local Brain Tumor Delivery
2026-08-11
The reference study developed a sprayable pectin hydrogel containing PLA-PEG-coated nanocrystals of Etoposide and olaparib for localized delivery after brain tumor resection. Its findings support a preclinical formulation strategy that combines bioadhesion, sustained drug release, sprayability, and distribution around a surgical cavity, while stopping short of demonstrating clinical tumor control.
-
Etoposide (VP-16) Experimental Workflow Guide
2026-08-10
Build more reproducible DNA damage and apoptosis experiments with Etoposide (VP-16), from DMSO stock preparation through orthogonal cell-death readouts. The guide emphasizes cell-line-specific potency, solvent control, topoisomerase-II biology, and practical troubleshooting for cancer chemotherapy research.
-
Berbamine hydrochloride in Ferroptosis Workflows
2026-08-09
Berbamine hydrochloride provides a practical perturbation tool for connecting STAT3, calcium homeostasis, NF-κB activity, and ferroptosis-related phenotypes in cancer models. This workflow-focused guide shows how to evaluate it in KU812 and HepG2 systems while separating cytotoxicity from pathway-specific effects.
-
Etoposide (VP-16): From DSBs to Genome Control
2026-08-08
Etoposide (VP-16) is more than a cytotoxicity reagent. This thought-leadership guide shows how its topoisomerase II mechanism can support DNA damage assays, apoptosis induction in cancer cells, and a translational framework for studying nuclear cGAS, genome integrity, and LINE-1 control.